Skip to main content

Citizens for Legitimate Government

News on U.S. imperialism, corpora-terrorism, and the New World Order

 

Click here!

 
Contribute to CLG

 

CLG Breaking News and Commentary

User login

NJ Drug Company Execs Charged With Insider Trading

November 19, 2012 by legitgov

NJ Drug Company Execs Charged With Insider Trading 19 Nov 2012 Two pharmaceutical company executives are among six people charged in what federal authorities in New Jersey are calling a five-year insider trading scheme. John Lazorchak was director of financial reporting at Celgene Corp. and Mark Cupo held a similar position at Sanofi-Aventis. The U.S. attorney's office in New Jersey says that between 2007 and 2012, Lazorchak and Cupo passed privileged information on their companies' merger and acquisition plans, financial results and regulatory applications to others who would make stock trades.

Premium Drupal Themes by Adaptivethemes